1438393-74-8

Basic information

• Product Name: (4-methoxyphenyl)(5H-pyrimido[5,4-b]indol-4-yl)methanone
• Synonyms: (4-methoxyphenyl)(5H-pyrimido[5,4-b]indol-4-yl)methanone
• CAS NO: 1438393-74-8
• Molecular Weight: 303.32
• Mol File: 1438393-74-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (4-methoxyphenyl)(5H-pyrimido[5,4-b]indol-4-yl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (4-methoxyphenyl)(5H-pyrimido[5,4-b]indol-4-yl)methanone(1438393-74-8)
• EPA Substance Registry System: (4-methoxyphenyl)(5H-pyrimido[5,4-b]indol-4-yl)methanone(1438393-74-8)

Safety Data

• Hazardous Substances Data: 1438393-74-8(Hazardous Substances Data)

Upstream product

• 57778-93-5 1H-indol-3-amine hydrochloride 
• 1438393-65-7 diethyl 5H-pyrimido[5,4-b]indole-2,4-dicarboxylate 
• 1438393-71-5 ethyl 4-(hydroxymethyl)-5H-pyrimido[5,4-b]indole-2-carboxylate 
• 1438393-72-6 2-(ethoxycarbonyl)-5H-pyrimido[5,4-b]indole-4-carboxylic acid 
• 100-66-3 methoxybenzene 
• 1438393-73-7 ethyl 4-(4-methoxybenzoyl)-5H-pyrimido[5,4-b]indole-2-carboxylate 
• 1438393-76-0 5H-pyrimido-[5,4-b]indole-4-carboxylic acid 
• 771-50-6 1H-indole-3-carboxylic acid 
• 1199215-71-8 tert-butyl 1H-indol-3-ylcarbamate 

Downstream Products

• 1438393-75-9 (4-hydroxyphenyl)(5H-pyrimido[5,4-b]indol-4-yl)methanone 

Relevant articles and documents

Design and Synthesis of Aza-β-Carboline Analogs and their Antibacterial Evaluation

Bacterial drug resistance has become a growing problem worldwide due to the excessive use of antibiotics in recent decades. Two small focused libraries of 5H-pyrimido[5,4-b]indole-4-carboxamides and 5H-pyrimido-[5,4-b]indole-4-ketones were designed as eudistomin Y3 and 1-acetyl-β-carboline (1-ABC) analogs and prepared via application of Inverse Electron-Demand Diels-Alder (IEDDA) reaction of 1,3,5-triazines and 3-aminoindoles. Compounds 2a and 2b were discovered to have activity against Mycobacterium bovis BCG with Minimum Inhibitory Concentration (MICs) values of 25 and 50 μg/mL respectively while compound 2e was against all three strains of Candida albicans tested with MIC values of 50 μg/mL. Moreover, compound 2e demonstrated synergistic antibacterial activity with fluconazol, which suggested that future drug candidates from this class of compounds could be used in combination with existing drugs to treat C. albicans infections.